Plus   Neg

Cincinnati Bell, Brookfield Amend Merger Agreement; Deal Now Valued At $2.80 Bln

Cincinnati Bell Inc. (CBB) has amended its merger agreement with Brookfield to raise the consideration payable to holders of outstanding shares of Cincinnati Bell stock to $13.50 per share from $12.50 per share. The amendment followed the receipt by Cincinnati Bell of a binding proposal, valued at $13.50 per share, from Macquarie Infrastructure and Real Assets Inc.

Cincinnati Bell's Board approved the amended merger agreement with Brookfield and recommended that shareholders vote in favor of adopting the amended merger deal.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL.
Follow RTT